Comparison between C2C Advanced Systems IPO and Onyx Biotec IPO.
C2C Advanced Systems IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Onyx Biotec IPO is a SME Bookbuilding proposed to list at NSE SME.
| C2C Advanced Systems IPO | Onyx Biotec IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Beeline Capital Advisors Pvt.Ltd. | Horizon Management Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MAS Services Ltd. |
| Market Maker | Spread X Securities Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of C2C Advanced Systems IPO is up to ₹94.11 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹27.85 Cr. The final issue price of C2C Advanced Systems IPO is ₹226.00 per share and of Onyx Biotec IPO is ₹61.00 per share.
| C2C Advanced Systems IPO | Onyx Biotec IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹214.00 per share | ₹58.00 per share |
| Issue Price (Upper) | ₹226.00 per share | ₹61.00 per share |
| Issue Price (Final) | ₹226.00 per share | ₹61.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 600 shares | 2000 shares |
| Fresh Issue Size | 41,64,000 shares | 45,66,000 shares |
| Fresh Issue Size (Amount) | up to ₹94.11 Cr | up to ₹27.85 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 41,64,000 shares | 45,66,000 shares |
| Issue Size Total (Amount) | up to ₹94.11 Cr | up to ₹27.85 Cr |
C2C Advanced Systems IPO opens on Nov 22, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of C2C Advanced Systems IPO and Onyx Biotec IPO is Nov 26, 2024, and Nov 18, 2024, respectively.
| C2C Advanced Systems IPO | Onyx Biotec IPO | |
|---|---|---|
| Anchor Bid Date | Nov 21, 2024 | Nov 12, 2024 |
| Issue Open | Nov 22, 2024 | Nov 13, 2024 |
| Issue Close | Nov 26, 2024 | Nov 18, 2024 |
| Basis Of Allotment (Tentative) | Nov 29, 2024 | Nov 19, 2024 |
| Initiation of Refunds (Tentative) | Dec 02, 2024 | Nov 20, 2024 |
| Credit of Share (Tentative) | Dec 02, 2024 | Nov 20, 2024 |
| Listing date (Tentative) | Dec 03, 2024 | Nov 22, 2024 |
| Anchor Lockin End date 1 | Dec 31, 2024 | Dec 19, 2024 |
| Anchor Lockin End date 2 | Mar 01, 2025 | Feb 17, 2025 |
C2C Advanced Systems IPO P/E ratio is 22.56, as compared to Onyx Biotec IPO P/E ratio of 26.81.
| C2C Advanced Systems IPO | Onyx Biotec IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | C2C Advanced Systems Limited Financial Information (Restated)C2C Advanced Systems Limited's revenue increased by 412% and profit after tax (PAT) rose by 327% between the financial year ending with March 31, 2024 and March 31, 2023.
| Onyx Biotec Limited Financial Information (Restated)Onyx Biotec Limited's revenue increased by 35.99% and profit after tax (PAT) rose by 64.35% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 56.52 | 88.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 22.56 | 26.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹376.09 Cr. | ₹110.61 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 4.99% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 3.71% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.15 | 1.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.02 | ₹2.28 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 11.29% | 4.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the C2C Advanced Systems IPO Retail Individual Investors (RII) are offered 14,57,400 shares while in Onyx Biotec IPO retail investors are offered 14,57,400 shares. Qualified Institutional Buyers (QIB) are offered 8,32,800 shares in C2C Advanced Systems IPO and 9,12,000 shares in Onyx Biotec IPO.
| C2C Advanced Systems IPO | Onyx Biotec IPO | |
|---|---|---|
| Anchor Investor Reserveration | 12,49,200 shares | 13,66,000 shares |
| Market Maker Reserveration | 2,19,600 shares | 2,44,000 shares |
| QIB | 8,32,800 shares | 9,12,000 shares |
| NII | 6,24,600 shares | 6,88,000 shares |
| RII | 14,57,400 shares | 16,00,000 shares |
| Employee | ||
| Others | ||
| Total | 41,64,000 shares | 45,66,000 shares |
C2C Advanced Systems IPO subscribed 125.35x in total, whereas Onyx Biotec IPO subscribed 198.00x.
| C2C Advanced Systems IPO | Onyx Biotec IPO | |
|---|---|---|
| QIB (times) | 31.61x | 32.49x |
| NII (times) | 233.13x | 602.86x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 132.73x | 118.26x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 125.35x | 198.00x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
